Bird & Bird advises MedtecLIVE on trade fair acquisition

Contacts

michael gassner module
Michael Gaßner

Senior Counsel
Germany

I work as a Counsel in our Munich corporate team, advising German and international clients on issues in corporate and commercial law, with a particular focus on technology and communications and life sciences.

International law firm Bird & Bird has advised MedtecLIVE GmbH, a subsidiary of NürnbergMesse, on the acquisition of the trade fair T4M - Technology for Medical Devices from Messe Stuttgart. The transaction took place as part of an asset deal; the parties have agreed not to disclose the purchase price.



MedtecLIVE GmbH will combine T4M with its own existing event MedtecLIVE to create a trade fair for the entire value chain of medical technology. The combined trade fair will be held annually, alternating between Messe Stuttgart and the Nürnberg Exhibition Centre.

With this purchase, MedtecLIVE is responding to the urgent need of the industry for a single, central European Spring event in southern Germany that integrates both the strong medical technology regions of Stuttgart/Tuttlingen and Nürnberg/Erlangen. Partners, associations, and supporters of both existing trade fairs have already pledged their support for the new trade fair format.

The following lawyers advised NürnbergMesse on the deal: Counsel Michael Gaßner (lead) and partner Stefan Münch (both Corporate/M&A, Munich), partner Dr. Henriette Picot, (IT/Data Protection, Munich), partner Dr. Jörg Witting, and associate Maren Steiert (both EU- & Competition, Düsseldorf).

News & Deals

More News & Deals
Deal Bird & Bird advises shareholders of The Payments Association on partnership with Nineteen Group

Aug 07 2025

Read More
News Bird & Bird boosts Dispute Resolution team in Singapore

Aug 06 2025

Read More
Deal Bird & Bird acts for Cornerstone Investors in US$140m placing by Rockhopper Exploration

Aug 06 2025

Read More
Deal Bird & Bird advises ACTUM Digital on Strategic Acquisition of Kuehlhaus AG

Aug 05 2025

Read More
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More
Deal Bird & Bird advises Everystate on its seed funding round

Jul 30 2025

Read More